84-1175-22 FLK1 (Vascular Endothelial Growth Factor Receptor 2, VEGFR-2, Fetal Liver Kinase 1, FLK-1, Kinase NYK, Protein-tyrosine Kinase Receptor flk-1, CD309, Kdr, Flk-1, Flk1) 100ul F4565-08A

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Embryonic vascular system undergoes a series of complex, highly regulated series of events involving differentiation, migration and association of primitive endothelial cells.
  • This process is termed vasculogenesis.
  • A further remodeling of the primitive vascular system forms the mature cardiovascular system.
  • This process is known as angiogenesis (sprouting of new capillary vessels from pre-existing vasculature).
  • Study of tumor angiogenesis has led to the identification of several proteins including basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF).
  • VEGF acts by interacting with a family of largely endothelial-specific receptor tyrosine kinases that includes VEGFR-1 (flt-1 or fms-like tyrosine kinase 1), VEGFR-2 (flk-1 or fetal liver kinase-1/KDR or Kinase insert domain containing receptor), and VEGFR-3/Flt-4.
  • Disruption of VEGFRs interferes with differentiation of endothelial cells and it is lethal for the embryo.
  • FLK-1 (Fetal-Liver Kinase 1; human homolog is KDR, Kinase insert domain containing receptor or VEGF-R2; mouse 1345aa; rat 1343aa, and human 1356), a putative receptor protein tyrosine kinase.
  • FLK-1 belongs to the family of type-1 membrane protein.
  • Human FLK-1 protein: 1-19 signal peptide, 20-1356 mature protein (20-764 extracellular domain, 765-789 TM, and 790-1356 cytoplasmic domain).FLK-1 Receptor for VEGF or VEGFC.
  • Has a tyrosine-protein kinase activity.
  • The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability.
  • It is expressed in endothelial cells of developing embryo.
  • It is also expressed at high levels in adult heart, lung, kidney, brain and skeletal muscle, but is also expressed at lower levels in most other adult tissues.
  • Applications:Suitable for use in Western Blot, ELISA, and Immunohistochemistry.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:1200-1:500 (Chemiluminescence)ELISA: 1:10,000-1:100,000; 50-100ng of control peptide/wellImmunohistochemistry: 2-20ug/ml Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Lyophilized powder may be stored at -20°C.
  • Stable for 12 months at -20°C.
  • Reconstitute with sterile ddH2O or PBS.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Reconstituted product is stable for 12 months at -20°C.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
  • Further dilutions can be made in assay buffer.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:mouse
  • Grade:Affinity Purified
  • Purity:Purified by immunoaffinity chromatography.
  • Form:Supplied as a lyophilized powder from PBS, 0.05% sodium azide.
  • Specificity:Recognizes mouse FLK1. Species Crossreactivity: rat and human.
  • Isotype:IgG
  • Calc Applications Abbrev:E IHC WB
  • Calc Crossreactivity:Hu Mo Rt
  • Immunogen:Synthetic peptide corresponding to 20aa of mouse FLK1, C-terminal, Cytoplasmic domain (KLH).
  • Shelf Life:1year
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1175-22
型番
F4565-08A
入り数
1個
標準価格
240,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る